Xu W - Search Results

1

Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase.

Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Guo H, Zhou L, Elstrom R, Huang J, Novotny W, Wei R, Zhu J. Song Y, et al. Among authors: xu w. Clin Cancer Res. 2020 Aug 15;26(16):4216-4224. doi: 10.1158/1078-0432.CCR-19-3703. Epub 2020 May 27. Clin Cancer Res. 2020. PMID: 32461234 Clinical Trial.

2

[A case report of misdiagnosed mantle cell lymphoma].

Yu H, Xu W, Wu YJ, Cheng YX, Qiu HR, Zhang SJ, Sheng RL, Li JY. Yu H, et al. Among authors: xu w. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):1112-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17956702 Chinese.

3

[Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].

Xu W, Li JY, Zhang ZH, Qiu HX, Qian SX, Wu HX, Lu H, Sheng RL. Xu W, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):933-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718094 Clinical Trial. Chinese.

4

[IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia].

Qian SX, Li JY, Wu HX, Zhang R, Hong M, Xu W, Qiu HX. Qian SX, et al. Among authors: xu w. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):464-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19379589 Clinical Trial. Chinese.

5

High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.

Xu W, Miao KR, Hong M, Zhu DX, Fang C, Dong HJ, Wang DM, Cao X, Li JY. Xu W, et al. Eur J Cancer. 2010 Aug;46(12):2145-9. doi: 10.1016/j.ejca.2010.04.021. Epub 2010 Jun 4. Eur J Cancer. 2010. PMID: 20627536

6

Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia.

Xu W, Miao KR, Zhu DX, Fang C, Zhu HY, Dong HJ, Wang DM, Wu YJ, Qiao C, Li JY. Xu W, et al. Int J Cancer. 2011 May 1;128(9):2192-201. doi: 10.1002/ijc.25560. Int J Cancer. 2011. PMID: 20635386 Free article. Clinical Trial.

7

SOX11 expression in mantle cell lymphoma.

Xu W, Li JY. Xu W, et al. Leuk Lymphoma. 2010 Nov;51(11):1962-7. doi: 10.3109/10428194.2010.514968. Epub 2010 Oct 4. Leuk Lymphoma. 2010. PMID: 20919851 Review.

8

[Expression of cyclic nucleotide phosphodiesterase 7B in patients with mantle cell lymphoma and its prognostic significance].

Dong HJ, Fan L, Wang DM, Fang C, Zhu DX, Wang YH, Hong M, Zhu Y, Qiao C, Zhuang Y, Xu W, Li JY. Dong HJ, et al. Among authors: xu w. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):94-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21362230 Chinese.

9

[Cytogenetic study of mantle cell lymphoma].

Wang DM, Fan L, Fang C, Zhu DX, Dong H, Yang H, Qiu HR, Hong M, Qiao C, Xu W, Li JY. Wang DM, et al. Among authors: xu w. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Jun;28(3):283-6. doi: 10.3760/cma.j.issn.1003-9406.2011.03.010. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011. PMID: 21644224 Chinese.

10

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.

Dong HJ, Zhou LT, Fang C, Fan L, Zhu DX, Wang YH, Li JY, Xu W. Dong HJ, et al. Among authors: xu w. Med Oncol. 2012 Sep;29(3):2166-73. doi: 10.1007/s12032-011-0096-5. Epub 2011 Nov 6. Med Oncol. 2012. PMID: 22057359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28,125 results

Search Page